Literature DB >> 19220774

IL13 variants are associated with total serum IgE and early sensitization to food allergens in children with atopic dermatitis.

Simona Eva Zitnik1, Franz Rüschendorf, Sebastian Müller, Claudia Sengler, Young-Ae Lee, Rupino W Griffioen, Paolo Meglio, Ulrich Wahn, Heiko Witt, Renate Nickel.   

Abstract

Increased total and specific serum immunoglobulin E (IgE) levels are common characteristics of atopic diseases and their basal production is proposed to be under strong genetic control. Interleukin 13 (IL13) variants have been consistently associated with total serum IgE levels in white populations with a strongest association in non-atopics. The aim of this study was to test the IL13 p.R130Q and c.1-1111C>T variants in children with atopic dermatitis (AD) for associations with total serum IgE and early sensitization to common food and inhalant allergens and with asthma. We included 453 children with AD [participants of the Early Treatment of the Atopic Child (ETAC) study] that were followed from the age of 12-24 months for 3 yr. Total and specific IgE were determined at four time points. We genotyped the IL13 p.R130Q and c.1-1111C>T variants by melting curve analysis. In children up to 4 yr of age, the 130Q allele was related to slightly higher total IgE levels compared to heterozygotes and 130R homozygotes. More importantly, both IL13 variants were significantly associated with sensitization to food allergens, with most significant results for sensitization to egg (p = 0.0001). Although early sensitization to hen's egg represents a strong risk factor for subsequent sensitization to inhalant allergens and asthma, the investigated IL13 variants were not associated with these phenotypes at the age of 48-60 months. In summary IL13 variants contribute to elevated levels of total serum IgE in young atopic children and are strongly associated with sensitization to food allergens, particularly to hen's egg. These findings suggest that IL13 variants play a major role not only in non-cognate but also in allergen specific IgE synthesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19220774     DOI: 10.1111/j.1399-3038.2008.00815.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  5 in total

Review 1.  The current state of food allergy therapeutics.

Authors:  Meng Chen; Michael Land
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

2.  IgE-mediated systemic anaphylaxis and impaired tolerance to food antigens in mice with enhanced IL-4 receptor signaling.

Authors:  Clinton B Mathias; Suejy A Hobson; Maria Garcia-Lloret; Greg Lawson; Dimitri Poddighe; Eva-Jasmin Freyschmidt; Wei Xing; Michael F Gurish; Talal A Chatila; Hans C Oettgen
Journal:  J Allergy Clin Immunol       Date:  2010-12-17       Impact factor: 10.793

Review 3.  The future of biologics: applications for food allergy.

Authors:  Rebecca N Bauer; Monali Manohar; Anne Marie Singh; David C Jay; Kari C Nadeau
Journal:  J Allergy Clin Immunol       Date:  2015-02       Impact factor: 10.793

Review 4.  Food allergy: immune mechanisms, diagnosis and immunotherapy.

Authors:  Wong Yu; Deborah M Hussey Freeland; Kari C Nadeau
Journal:  Nat Rev Immunol       Date:  2016-10-31       Impact factor: 53.106

5.  Coexistence of 2282del4 FLG gene mutation and IL-18 -137G/C gene polymorphism enhances the risk of atopic dermatitis.

Authors:  Magdalena Trzeciak; Jolanta Gleń; Krzysztof Rębała; Tadeusz Bandurski; Monika Sikorska; Roman Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2016-02-29       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.